The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation

Anesthesia and Analgesia

Volumn 112, Issue 2, 2011, Pages 319-321

  Boone, James D ^a   Sherwani, Saadia S ^a   Herborn, Joshua C ^a   Patel, Kinjal M ^a   De Wolf, Andre M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALTEPLASE; FRESH FROZEN PLASMA; HEPARIN; NORADRENALIN; PHENYLEPHRINE;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTERY ANASTOMOSIS; ARTERY CATHETERIZATION; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD TRANSFUSION; BRADYCARDIA; CASE REPORT; CENTRAL VENOUS PRESSURE; CRYOPRECIPITATE; EARLY DIAGNOSIS; ERYTHROCYTE CONCENTRATE; FATTY LIVER; FEMALE; FLUID RESUSCITATION; HEART ATRIUM THROMBOSIS; HEPATITIS C; HEPATOMEGALY; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTRACARDIAC THROMBOSIS; LIVER CELL CARCINOMA; LIVER CONGESTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG THROMBOSIS; MALE; MULTIPLE ORGAN FAILURE; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY ARTERY CATHETER; PULMONARY HYPERTENSION; PULSE OXIMETRY; THROMBOCYTE TRANSFUSION; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 79251645593     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ANE.0b013e31820472d4     Document Type: Article

References (11)

1. Gologorsky E, De Wolf AM, Scott V, Aggarwal S, Dishart M, Kang Y. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl 2001;7:783-9
2. Warnaar N, Molenaar Q, Colquhoun SD, Slooff MJ, Sherwani S, De Wolf AM, Porte RJ. Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. J Thromb Haemost 2008;6:297-302
3. Lerner AB, Sundar E, Mahmood F, Sarge T, Hanto DW, Panzica PJ. Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs. Anesth Analg 2005;101:1608-12
4. Chartier L, Béra J, Delomez M, Asseman P, Beregi JP, Bauchart JJ, Warembourg H, Théry C. Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients. Circulation 1999;99:2779-83
5. Thabut G, Thabut D, Myers RP, Bernard-Chabert B, Marrash-Chahla R, Mal H, Fournier M. Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am Coll Cardiol 2002;40:1660-7
6. Jackson D, Botea A, Gubenko Y, Delphin E, Bennett H. Successful intraoperative use of recombinant tissue plasminogen activator during liver transplantation complicated by massive intracardiac/pulmonary thrombosis. Anesth Analg 2006;102:724-8
7. O'Conner CJ, Roozeboom D, Brown R, Tuman KJ. Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drugs and novel treatment options. Anesth Analg 2000;91:296-9
8. Groenland TH, Porte RJ. Antifibrinolytics in liver transplantation. Int Anesth Clin 2006;44:83-97
9. Kahl BS, Schwartz BS, Mosher DF. Profound imbalance of pro-fibrinolytic and anti-fibrinolytic factors (tissue plasminogen activator and plasminogen activator inhibitor type 1) and severe bleeding diathesis in a patient with cirrhosis: correction by liver transplantation. Blood Coagul Fibrinolysis 2003;14:741-4
10. Bakker CM, Metselaar HJ, Groenland TN, Gomes MJ, Knot EA, Hesselink EJ, Schalm SW, Stibber J, Terpstra OT. Increased tissue-type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: the role of the anhepatic period. Hepatology 1992;16:404-8
11. Genentech, Inc. Activase (alteplase, recombinant) [product information brochure]. San Francisco: Genentech, Inc., 2005